Male
Joseph Siletto began working with Vivo as an advisor in 2015. At Vivo, Mr. Siletto is actively working on cross-border transactions between Chinese and U.S. or European companies. Mr. Siletto has over 15 years of experience in life sciences transactions and investments as a private company CEO, investment banker and a private investor. Mr. Siletto was most recently the U.S. CEO of a China-focused global medical device company, where he orchestrated five acquisitions and both FDA and CE mark approval of the company’s products. Earlier in his career, Mr. Siletto was an investment banker involved in over 50 transactions totaling over $1 billion for biopharmaceutical and medical device companies while working for Cowen & Co. and Banc of America Securities.
Headlines from Google News. Social posts load from the platform only when you open a tab.
Endpoints News · Nov 7
Alternatives Watch · Jul 12
PR Newswire · Jul 11
Endpoints News · Jul 11
citybiz · Oct 26